QUANTERIX CORP (QTRX) Stock Price, Forecast & Analysis
USA - NASDAQ:QTRX - US74766Q1013 - Common Stock
QTRX Key Statistics, Chart & Performance
The current stock price of QTRX is 5.74 USD. In the past month the price decreased by -2.05%. In the past year, price decreased by -49.83%.
QTRX Latest News, Press Relases and Analysis
QTRX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.84 | 218.53B | ||
| DHR | DANAHER CORP | 28.69 | 158.40B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 161.67 | 49.06B | ||
| A | AGILENT TECHNOLOGIES INC | 26.94 | 41.62B | ||
| IQV | IQVIA HOLDINGS INC | 18.97 | 37.50B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.53 | 28.90B | ||
| WAT | WATERS CORP | 29.87 | 22.58B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.97 | 18.79B | ||
| ILMN | ILLUMINA INC | 27.68 | 18.55B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.27 | 16.58B | ||
| TEM | TEMPUS AI INC | N/A | 11.90B | ||
| RVTY | REVVITY INC | 19.36 | 10.76B |
Related stock screener links
About QTRX
Company Profile
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Company Info
QUANTERIX CORP
900 Middlesex Turnpike
Billerica MASSACHUSETTS 01821 US
CEO: E. Kevin Hrusovsky
Employees: 471
Phone: 16173019400
QUANTERIX CORP / QTRX FAQ
Can you describe the business of QUANTERIX CORP?
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 471 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
What is the stock price of QUANTERIX CORP today?
The current stock price of QTRX is 5.74 USD. The price increased by 7.89% in the last trading session.
Does QTRX stock pay dividends?
QTRX does not pay a dividend.
How is the ChartMill rating for QUANTERIX CORP?
QTRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for QUANTERIX CORP?
QUANTERIX CORP (QTRX) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the market cap for QUANTERIX CORP?
QUANTERIX CORP (QTRX) has a market capitalization of 266.74M USD. This makes QTRX a Micro Cap stock.
Can you provide the ownership details for QTRX stock?
You can find the ownership structure of QUANTERIX CORP (QTRX) on the Ownership tab.
QTRX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to QTRX. When comparing the yearly performance of all stocks, QTRX is a bad performer in the overall market: 79.5% of all stocks are doing better.
QTRX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to QTRX. QTRX has a great financial health rating, but its profitability evaluates not so good.
QTRX Financial Highlights
Over the last trailing twelve months QTRX reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS decreased by -55.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.77% | ||
| ROE | -24.11% | ||
| Debt/Equity | 0 |
QTRX Forecast & Estimates
9 analysts have analysed QTRX and the average price target is 6.38 USD. This implies a price increase of 11.06% is expected in the next year compared to the current price of 5.74.
For the next year, analysts expect an EPS growth of -160.45% and a revenue growth -2.36% for QTRX